Advertisement
Original Articles| Volume 138, ISSUE 5, P313-321, November 2001

Pitfalls in preparation of 3H-unconjugated bilirubin by biosynthetic labeling from precursor 3H-5-aminolevulinic acid in the dog

      Abstract

      We report problems encountered during preparation of tritium-labeled unconjugated bilirubin (3H-UCB) from precursor 3H-5-aminolevulinic acid (3H-ALA) in 2 dogs with external biliary drainage installed into the animals under general anesthesia. Under prolonged sedation, 12.9 or 14.0 mCi of 3H-ALA was administered intravenously in two divided doses, and bile was collected for 9 hours. In one animal, taurocholate (TC) infusion was needed to maintain bile flow. 3H-UCB was isolated from the bile and recrystallized with the improved method of Webster et al (Webster CC, Tiribelli C, Ostrow JD. J Lab Clin Med 2001;137:370-3). Based on radioactivity and pigment content, hourly bile collections were pooled to optimize specific activities. Surprisingly, in the first dog, only 2.9% of injected radioactivity was recovered in bile and only 14.1% in urine, and the specific activities of the crystalline 3H-UCB from the two pools were only 39.5 and 30.0 × 103 dpm/μg. High-performance liquid chromatography analysis revealed that only 4% of ALA degraded during 5 minutes in injection solution at pH 6.8. The low incorporation of 3H-ALA and low specific activity of 3H-UCB was apparently caused mainly by prior degradation and exchange of labile tritium of the 3H-ALA and probably by enhanced endogenous ALA synthesis caused by the anesthetic/sedative agents. Revised procedures in the second dog improved the incorporation of 3H-ALA to 11.9% excreted in bile and the specific activity of the crystalline 3H-UCB to 122.0 and 50.8 × 103 dpm/μg, while urinary excretion of tritium increased to 28.5%. These experiences emphasize possible pitfalls in preparing 3H-UCB by biosynthetic labeling from 3H-ALA administered to dogs. (J Lab Clin Med 2001;138:313-21)

      Abbreviations:

      ALA (5-aminolevulinic acid), 3H-ALA (3H-labeled 5-aminolevulinic acid), AUC (area under the curve), HPLC (high-performance liquid chromatography), PBG (porphobilinogen), TC (sodium taurocholate), UCB (unconjugated bilirubin)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Oude Elferink RPJ
        • Meijer DKF
        • Kuipers F
        • Jansen PLM
        • Groen AK
        • Groothuis GMM.
        Hepatobiliary secretion of organic compounds: molecular mechanisms of membrane transport.
        Biochim Biophys Acta. 1995; 1421: 215-268
        • Ostrow JD
        • Mukerjee P
        • Tiribelli C.
        Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function.
        J Lipid Res. 1994; 35: 1715-1737
        • Webster CC
        • Tiribelli C
        • Ostrow JD.
        An improved method for isolation of unconjugated bilirubin from rat and dog bile.
        J Lab Clin Med. 2001; 137: 370-373
        • Ostrow JD
        • Hammaker L
        • Schmid R.
        The preparation of crystalline bilirubin-C14.
        J Clin Invest. 1961; 40: 1442-1452
        • Barrett PVD
        • Mullins FX
        • Berlin NI
        Studies on the biosynthetic production of bilirubin-C14: an improved method utilizing δ-aminolevulinic acid-4-C14 in dogs.
        J Lab Clin Med. 1966; 68: 905-912
        • Boivin P
        • Galand C
        • Berthelot P
        • Fauvert R.
        Preparation de bilirubine C14 cristallisée.
        Rev Franç Études Clin Biol. 1967; 12: 831-832
        • Lester R
        • Klein PD.
        Biosynthesis of tritiated bilirubin and studies of its excretion in the rat.
        J Lab Clin Med. 1966; 67: 1000-1012
        • Howe RB
        • Berk PD
        • Bloomer JR
        • Berlin NI.
        Preparation and properties of a specifically labeled radiochemically stable 3H-bilirubin.
        J Lab Clin Med. 1970; 75: 499-502
        • Roy Chowdhury J
        • Roy Chowdhury N
        • Wolkoff AW
        • Arias IM.
        Heme and bile pigment metabolism. In: Arias IM et al, editors. The liver: biology and pathobiology.
        in: Raven Press, New York1994: 505-528
        • McDonagh AF
        • Assisi F.
        The ready isomerization of bilirubin-IXα in aqueous solution.
        Biochem J. 1972; 129: 797-800
        • Robinson SH.
        Formation of bilirubin from erythroid and non-erythroid sources.
        Semin Hematol. 1972; 9: 43-54
        • Hahm JS
        • Ostrow JD
        • Mukerjee P
        • Celic L.
        Ionization and self-association of unconjugated bilirubin, determined by rapid solvent partition from chloroform, with further studies of bilirubin solubility.
        J Lipid Res. 1992; 33: 1123-1137
        • Novo M
        • Huttmann G
        • Diddens H.
        Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumors.
        J Photochem Photobiol B. 1996; 34: 143-148
        • Spivak W
        • Yuey W.
        Application of a rapid and efficient h.p.l.c. method to measure bilirubin and its conjugates from native bile and in model bile systems. Potential use as a tool for kinetic reactions and as an aid in diagnosis of hepatobiliary disease.
        Biochem J. 1986; 234: 101-109
        • Cruz WO
        • Hawkins WB
        • Whipple GH.
        Acetylphenylhydrazine anemia. 2. Bile pigment elimination and new hemoglobin reconstruction in the bile fistula dog.
        Am J Med Sci. 1942; 203: 848-854
        • Small DM
        • Dowling RH
        • Redinger RN.
        The enterohepatic circulation of bile salts.
        Arch Intern Med. 1972; 130: 552-573
        • Watkins JB.
        Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
        J Pharmacol Exp Ther. 1989; 250: 421-427
        • Dover SB
        • Plenderleith L
        • Moore MR
        • McColl KEL.
        Safety of general anaesthesia and surgery in acute hepatic porphyria.
        Gut. 1994; 35: 1112-1115
        • Harrison GG
        • Meissner PN
        • Hift RJ.
        Anaesthesia for the porphyric patient.
        Anaesthesia. 1993; 48: 417-421
        • Dalton JT
        • Meyer MC
        • Golub AL.
        Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
        Drug Metab Dispos. 1999; 27: 432-435
        • Elfsson B
        • Wallin I
        • Eksborg S
        • Rudaeus K
        • Ros AM
        • Ehrsson H.
        Stability of 5-aminolevulinic acid in aqueous solution.
        Eur J Pharm Sci. 1999; 7: 87-91
        • Jaffe EK
        • Rajagopalan JS.
        Nulcear magnetic resonance studies of 5-aminolevulinate demonstrate multiple forms in aqueous solution.
        Bioorganic Chemistry. 1990; 18: 381-394
        • Butler AR
        • George S.
        The nonenzymatic cyclic dimerization of 5-aminolevulinic acid.
        Tetrahedron. 1992; 48: 7879-7886
        • Monteiro HP
        • Bechara EJH
        • Abdalla DSP.
        Free radicals involvement in neurological porphyrias and lead poisoning.
        Mol Cell Biochem. 1991; 103: 73-83
        • Monteiro HP
        • Abdalla DSP
        • Augusto O
        • Bechara EJH
        Free radical generation during δ-aminolevulinic acid autooxidation: induction by hemoglobin and connections with porphyrinopathies.
        Arch Biochem Biophys. 1989; 271: 206-216
        • Böhrer H
        • Schmidt H
        • Martin E
        • Lux R
        • Bolsen K
        • Goerz G.
        Testing the porphyrinogenecity of propofol in a primed rat model.
        Br J Anaesth. 1995; 75: 334-338
        • Hoshi K
        • Senda N
        • Fujino S.
        Acute effect of amitriptyline, phenobarbital or cobaltous chloride on delta-aminolevulinic acid synthetase, heme oxygenase and microsomal heme content and drug metabolism in rat liver.
        Jpn J Pharmacol. 1989; 50: 289-293
        • Okuda H
        • Tavoloni N
        • Blaschke TF
        • Kiang CL
        • Jones MJ
        • Waggoner JG
        • et al.
        Phenobarbital does not increase early labeling of bilirubin from 4-[14C]-delta-aminolevulinic acid in man and rat.
        Hepatology. 1991; 14: 1153-1160
        • Buzaleh AM
        • Vazquez ES
        • Nunez G
        • del Carmen Batlle AM.
        Effect of chronic anesthesia on the drug-metabolizing enzyme system and heme pathway regulation.
        Gen Pharmacol. 1997; 28: 577-582
        • Buzaleh AM
        • Batlle AM.
        Strain and sex differences in the effect of enflurane and isoflurane on heme metabolism in mice.
        Gen Pharmacol. 1996; 27: 1009-1012
        • Buzaleh AM
        • Enriquez de Salamanca R
        • Batlle AM.
        Effect of multiple doses of volatile anesthetics on heme enzymes.
        Gen Pharmacol. 1994; 25: 1179-1183
        • Buzaleh AM
        • Enriquez de Salamanca R
        • del Carmen Batlle AM.
        Administration of the anesthetic isoflurane to mice: a model for acute intermittent porphyria?.
        J Pharmacol Toxicol Methods. 1992; 28: 191-197
        • Buzaleh AM
        • Enriquez de Salamanca R
        • Batlle AM.
        Porphyrinogenic properties of the anesthetic enflurane.
        Gen Pharmacol. 1992; 23: 665-669
        • Parikh RK
        • Moore MR
        Effect of certain anaesthetic agents on the activity of rat hepatic δ-aminolaevulinate synthase.
        Br J Anaesth. 1978; 50: 1099-1103
        • Ostrow JD
        • Jandl JH
        • Schmid R.
        The formation of bilirubin from hemoglobin in vivo.
        J Clin Invest. 1962; 41: 1628-1637
        • Spivak W
        • Carey MC.
        Reverse-phase h.p.l.c. separation, quantification, and preparation of bilirubin and its conjugates from native bile. Quantitative analysis of the intact tetrapyrroles based on h.p.l.c. of their ethyl anthranilate azo derivatives.
        Biochem J. 1985; 225: 787-805